BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7471125)

  • 1. Doxorubicin and ricin, a strongly synergistic combination in mouse leukemia.
    Fodstad O; Pihl A
    Cancer Treat Rep; 1980; 64(12):1375-8. PubMed ID: 7471125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of adriamycin and ricin on L1210 leukemic cells in mice.
    Fodstad O; Pihl A
    Cancer Res; 1980 Oct; 40(10):3735-9. PubMed ID: 7438056
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
    Valeriote F; Vietti T; Coulter D
    J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ricin and abrin on survival of L1210 leukemic mice and on leukemic and normal bone-marrow cells.
    Fodstad O; Pihl A
    Int J Cancer; 1978 Nov; 22(5):558-63. PubMed ID: 721316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of abrin and ricin used singly and in combination with cisplatin.
    Walker EM; Gale GR; Glassman AB; Atkins LM; Bennett CE; Burgis JT
    Ann Clin Lab Sci; 1984; 14(1):10-20. PubMed ID: 6538076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
    Pazdernik TL; Uyeki EM
    J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1985 May; 74(5):1071-7. PubMed ID: 3858576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of lipoic acid and doxorubicin in murine leukemia.
    Dovinová I; Novotný L; Rauko P; Kvasnicka P
    Neoplasma; 1999; 46(4):237-41. PubMed ID: 10613604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of ricin in combination with daunorubicin, cis-dichlorodiammineplatinum(II) and vincristine in systemic L1210 leukemia.
    Fodstad O; Pihl A
    Cancer Res; 1982 Jun; 42(6):2152-8. PubMed ID: 7200398
    [No Abstract]   [Full Text] [Related]  

  • 10. alpha-Tocopherol pretreatment increases adriamycin bone marrow toxicity.
    Alberts DS; Peng YM; Moon TE
    Biomedicine; 1978 Oct; 29(6):189-91. PubMed ID: 737277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside.
    Presant CA; Vietti TJ; Valeriote F; Coulter DM
    J Natl Cancer Inst; 1981 Dec; 67(6):1283-8. PubMed ID: 6171666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined treatment of L1210 leukemia with adriamycin and pustulan.
    Fiszer-Maliszewska L; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):703-10. PubMed ID: 7349092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modification effects of AK-2123 on adriamycin to mouse leukemic cells].
    Hori Y; Zhou B
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1697-700. PubMed ID: 8060149
    [No Abstract]   [Full Text] [Related]  

  • 14. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model.
    Jamieson C; Richter A; Levy JG
    Exp Hematol; 1993 May; 21(5):629-34. PubMed ID: 8513863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antileukemic activity of combinations of two nitrosoureas.
    Wheeler GP; Schabel FM; Trader MW
    Cancer Treat Rep; 1981; 65(7-8):591-9. PubMed ID: 6454482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice.
    Vadlamudi S; Choudry JN; Waravdekar VS; Kline I; Goldin A
    Cancer Res; 1970 Feb; 30(2):362-9. PubMed ID: 5458970
    [No Abstract]   [Full Text] [Related]  

  • 18. The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds.
    Fariss MW; Fortuna MB; Everett CK; Smith JD; Trent DF; Djuric Z
    Cancer Res; 1994 Jul; 54(13):3346-51. PubMed ID: 8012947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of number of bone marrow stem cells in mice with L1210 leukemia.
    Chevalier C; Frindel E
    Biomedicine; 1973 Apr; 19(4):177-9. PubMed ID: 4715578
    [No Abstract]   [Full Text] [Related]  

  • 20. Pre- and co-treatment with xanthophyll enhances the anti-leukemic activity of adriamycin.
    Lee KH
    J Photochem Photobiol B; 2008 Sep; 92(3):175-9. PubMed ID: 18653355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.